This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Health Discovery Corporation Appoints John Hadden Senior Vice President Of National And International Business Development

Stocks in this article: HDVY

Health Discovery Corporation (OTCBB: HDVY) today announced the appointment of John R. Hadden to the position of Senior Vice President of National and International Business Development. An industry veteran with more than 26 years experience, Hadden brings to Health Discovery Corporation (HDC) a record of innovation and successes in the laboratory and healthcare fields. In his new role, Hadden is tasked with sales leadership and licensing of the Company’s products and technologies to clinical labs and medical diagnostics testing companies world-wide. He is also responsible for developing strategic alliances with these and other partners.

Most recently with Quest Diagnostics (NYSE: DGX), one of the largest commercial clinical laboratories in the world, Mr. Hadden oversaw a variety of wide-ranging assignments that included new product introductions, sales leadership, strategic alliances, and mergers and acquisitions. A former “Best of Quest” award winner, Mr. Hadden excelled at Quest for nearly eight years.

Prior to Quest Diagnostics, Mr. Hadden was Senior Vice President of Business Development at American Medical Laboratories, Inc. which was acquired by Quest Diagnostics in a transaction valued at $500 million. In addition, Mr. Hadden was Senior Vice President of National Business Development with LabOne, Inc. which was acquired by Quest Diagnostics in a transaction valued at $934 million. He also served as Associate Vice President for Laboratory Corporation of America (LabCorp).

“Throughout an impressive career with global, national and regional commercial clinical laboratories, John has accomplished a striking track record of success in all areas, from new product launches and sales leadership to mergers and acquisitions,” notes Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation. “We are thrilled to have his expertise to catapult the commercialization of Health Discovery’s products and technologies and to create strategic alliances driving the future of the Company.”

“I am honored to join Health Discovery Corporation and its distinguished team of world-renowned leaders and innovators at this very exciting time in the Company's development and commercialization cycle,” stated John Hadden, Senior Vice President for National and International Business Development. “I look forward to working closely with Dr. Barnhill to help bring commercial success to the tremendous pipeline of products, as well as developing strategic relationships to advance the goals of the Company.”

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs